This study evaluated a novel non-verbal communication method for people with severe motor and intellectual disabilities (SMID) based on a biochemical marker, salivary amylase. The physical and psychological status of 10 people with SMID was quantitatively evaluated using a hand-held salivary amylase activity monitor. Each patient needed daily gastric and/or bronchial tube exchanges and these medical procedures were thought to cause severe distress and pain. Salivary amylase activity and heart rate were simultaneously measured during 32 medical procedures. The medical procedures resulted in a significant mean increase for individuals of 70% in salivary amylase activity. The increase in salivary amylase activity was more than four-fold that observed for heart rate. The structural equation modelling analysis also demonstrated a significant correlation between pain and salivary amylase activity. Our data indicate that salivary amylase activity might be used as a non-verbal method of assessing pain in people with SMID.
Introduction
A communication system for children and adults with intellectual disabilities (ID) is a desirable assistive technology. 1, 2 Checklists consisting of multiple questionnaires have been used to assess the mental health of people with ID. 3 Currently, there are five wellresearched, comprehensive carer-completed checklists for assessing psychopathology in people with ID: the Psychopathology Instrument for Mentally Retarded Adults (PIMRA); 4 the Diagnostic Assessment Schedule for Severely Handicapped (DASH-II); 5 the Reiss Screen for Maladaptive Behavior (RSMB); 6 the Psychiatric Assessment Schedule for Adults with Development Disabilities Checklist (PAS-ADD Checklist); 7 and the Aberrant Behavior Checklist (ABC). 8 Furthermore, in order to obtain a more accurate assessment, a variety of other methods, including observing people's facial expressions and behaviour to assess whether pain and/or discomfort are being experienced, have been M Yamaguchi, K Takeda, M Onishi et al. Biochemical non-verbal communication in people with SMID studied. 9, 10 These subjective, checklist-based evaluations may help carers, nurses and family members to determine the physical and psychological status of people with ID.
A communication system that is based on the viewpoint of the individual with ID has not previously been considered. People with mild ID can show some of their emotions by using a body map, a mood scale or a pictorial scale. 11 -13 In contrast, people with severe motor and intellectual disabilities (SMID), whose IQ is below 50 and who are bedridden or who find it difficult to get out of bed, cannot properly convey their emotions of comfort (eustress or a positive psychological state) or discomfort (distress or a negative psychological state) to others.
In an attempt to measure the physical and psychological status of healthy people objectively and quantitatively, various methods have evaluated the activity of the autonomic nervous system using electroencephalogram (EEG), electrocardiogram (ECG), skin conductance and heart rate. 14 -16 These physical measurements require the subjects to be physically restrained, however. The authors propose a novel non-verbal communication method for people with SMID that is based on a biochemical marker, salivary amylase activity. Salivary amylase activity can be a useful index of plasma norepinephrine under a variety of stressful conditions, since it appears that increased sympathetic nervous activity is a major stimulator of amylase secretion. 17 We have developed a method that can rapidly quantify salivary amylase activity, and we have manufactured a hand-held salivary amylase activity monitor. 18 -20 Sampling saliva has the advantage that it is noninvasive, which makes multiple sampling easy and does not stress the patient.
Medical procedures such as replacing gastric and bronchial tubes that are used to help sustain life in people with SMID could cause severe distress and pain. The purpose of this study was to validate the biochemical marker, salivary amylase activity, as an indicator of pain in people with SMID who required the daily replacement of gastric and/or bronchial tubes, the latter of which were associated with the use of artificial respirators. The physical and psychological status of people with SMID was observed before, during and after the medical procedures were performed by measuring changes in salivary amylase activity and heart rate.
Patients and methods

PATIENTS
In Japan, people with ID and severe intellectual (IQ < 50) and physical disabilities (bedridden or those who find it difficult to rise from bed) are categorized as people with SMID. This study enrolled people with SMID from the Ibaraki-higashi Hospital, which is part of the National Hospital Organization. The study protocol was approved by the Ethical Committee of the Institutional Review Board of the University of Tsukuba, Medical Branch (Tsukuba, Japan). The study protocol was fully explained to the guardians of all of the patients in both spoken and written forms, specifically focusing on the purpose of the study, the precise procedures that would be used and any possible adverse events. Signed informed consent was obtained for each person with SMID who enrolled in the study.
SALIVARY AMYLASE ACTIVITY MONITOR
A hand-held salivary amylase activity monitor with a saliva transcription device was manufactured. 20 This monitor consisted of a disposable test strip ( Fig. 1A) and an optical analyser (126 × 130 × 48 mm; 350 g; Fig. 1B ), which was incorporated within an automatic saliva transcription device. The test strip consisted of a collecting sheet attached to the collecting papers, and a holder to which a reagent paper was attached. A sample (20 -30 µl) of whole saliva was collected by placing the collecting paper under the tongue. When the test strip was examined by the optical analyser, the analysis was automatically controlled and the salivary amylase activity was shown on an electronic display after completion of the measurement.
A calibration curve for the hand-held monitor is shown in Fig. 2 . Based on the analytical results of the salivary amylase activity that were obtained using an enzymatic reagent method (Espa AMY liquid 2, Nipro Co., Osaka, Japan) and a clinical automatic analyser (Miracle Ace 919, Nipro Co.), the output voltage of the hand-held monitor was measured (n = 49) at 37 ºC. The coefficient of multiple determination of R 2 was 0.98 for a range of salivary amylase activities (10 -140 kU/l). The time required for collection of saliva was approximately 10 -30 s for each subject, and it took 30 s for saliva transfer and analysis using the handheld monitor; therefore, 1 min was sufficient to measure salivary amylase activity.
STUDY PROCEDURES
All patients had difficulty feeding themselves and were fed through a cervical duct using a gastric tube (14 fr [3 fr = 1 mm], Argyll, Tyco International Ltd, Bermuda). Patients who were incapable of spontaneous respiration because of severe brain damage were supported by an artificial respirator and a bronchial tube (4.5 mm or 7 mm of inner diameter, Portex Ltd, Hythe, UK) inserted into a tracheostomy. The gastric and bronchial tubes were regularly replaced with clean ones to ensure good hygiene. It was speculated that these medical procedures could cause severe distress and pain to FIGURE 1: The hand-held salivary amylase activity monitor consisted of a disposable test strip (A) and an optical analyser (B), which was incorporated within an automatic saliva transcription device. The test strip consisted of a collecting sheet attached to the collecting papers and a holder to which a reagent paper was attached. A sample (20 -30 µl) of whole saliva was collected by placing the collecting paper under the tongue. When the test strip was examined by the optical analyser, the analysis was automatically controlled and salivary amylase activity was shown on an electronic display Biochemical non-verbal communication in people with SMID people with SMID. Therefore, changes in the physiological status of patients with SMID were evaluated when these medical procedures were performed.
The physical and psychological status of each person with SMID was assessed by measuring salivary amylase activity and heart rate. The hand-held monitor was used for the analysis of salivary amylase activity, and a portable heart rate monitor (S610, Polar Electro Oy., Kempele, Finland) was used for the heart rate measurements. Saliva was collected and the heart rate was simultaneously measured every 3 min from approximately 10 min prior to initiation of the procedure to about 30 min after the procedure was completed (Fig. 3) . The length of time that the medical procedure took could not be precisely standardized because they varied depending on the time required for preparation of the procedure as well as the individual patient's condition. The duration was divided into the following three periods: the pre-treatment period (resting period) was the 6 min immediately prior to the medical procedure; the mid-treatment period was the period during the medical procedure; and the post-treatment period was the 6 min immediately after the medical procedure had been completed. The mean amylase activity and heart rate during the pre-treatment period were defined as AMY pre and HR pre , respectively. The maximum values for each parameter that was measured during the medical procedure were defined as AMY mid and HR mid . The mean amylase activity and heart rate during the post-treatment period were defined as AMY post and HR post .
The physical and psychological status of each patient, such as facial expressions and physical movements, were also recorded using a video camera (FV M100, Canon Inc., Tokyo, Japan) in order to estimate their levels of distress. The distress was divided into the following three levels: (i) Strong -the subject was considered to be under great stress due to a longer than normal duration for the medical procedure(s). The signs would be facial flushing or resistance; (ii) Medium -the subject was considered to be under medium levels of stress associated with the usual duration of around 5 min for the medical procedure(s). The signs would be bad temper, a coughing fit, vomiting or muscular tension; (iii) Mild -the subject was considered to be under low levels of stress due to a shorter than normal duration for the medical procedure(s). The signs would be an expressionless face, reflex motion or passivity. In addition, the medical procedures were categorized according to the following two pain levels: a low-level pain was associated with bronchial tube exchange; and a highlevel pain was associated with any procedure that included gastric tube exchange.
STATISTICAL ANALYSIS
A data analysis method known as structural equation modelling (SEM) was used to test specific hypotheses outlined in our conceptual model (Amos 5.0, SPSS Japan 
Biochemical non-verbal communication in people with SMID
Inc., Tokyo, Japan). SEM has already been used in several studies to assess questionnaires of people with ID. 21, 22 This analytical approach involves a two-step process. 23 In the first step, observed variables are hypothesized to measure the underlying constructs and tested using confirmatory factor analysis; this step leads to the measurement model including an unobserved variable. The second step focuses on testing hypotheses about relationships between the unobserved variable and the variables in the structural model. All of the hypothesized paths in a conceptual model were tested; however, only paths that were significant (P < 0.05) are shown in the final results. Distress and pain levels were used as the input variables, and salivary amylase activity and heart rate were used as the output variables.
Results
The study evaluated 10 people with SMID aged 5 -40 years (seven males and three females) ( Table 1 ). Patients C, E, G, I and J were incapable of spontaneous respiration due to severe brain damage and were supported by artificial respirators. The medical procedures evaluated in this study were 19 gastric tube exchanges, five bronchial tube exchanges and eight dual gastric and bronchial tube exchanges; in total, 32 separate medical procedures were evaluated in this experiment ( Table 2) . During the medical procedure, any major change that was observed in the physical and psychological status of the person with SMID was considered to be a reflex response to the pain/discomfort. The average duration of the procedure in 32 separate medical procedures was 5.4 min (range, 3.0 -18.0 min). During the medical procedures that involved the patients supported by an artificial respirator, the time taken to change the bronchial tube was limited to ≤ 15 s.
In patients A, B, D, F and H, who did not require the support of an artificial respirator, salivary amylase activity ranged from 6 to 162 (mean, 46.0) kU/l during the pre-, mid-and post-treatment periods. Their heart Biochemical non-verbal communication in people with SMID rates ranged from 51 to 187 (mean, 101.9) beats/min (bpm) in the same periods. In patients C, E, G, I and J, who required artificial respiration, the salivary amylase activity ranged from 4 to 112 (mean, 15.2) kU/l and their heart rates ranged from 69 to 144 (91.6) bpm in the same periods. With regard to both salivary amylase activity and heart rate, the mean values in the patients supported by artificial respiration were smaller than those of the patients who did not require artificial respiration.
The changes in amylase activity and heart rate that were observed in six typical patients during gastric tube exchange are shown in Fig. 4 . In most of the patients, salivary amylase activity and heart rate increased during the medical procedure, followed by a rapid decline in both parameters after the medical procedure was complete. During 32 separate procedures, the mean change in salivary amylase activity for individual patients in the midtreatment period was 70% (range, -44.7 -489.5%) above that of the pre-treatment period. In contrast, the mean change in heart rate was 15.1%, and the largest change was observed in subject F (55.6%). The change in salivary amylase activity was more than four times greater than that of heart rate.
Comparison of salivary amylase activity between pre-, mid-and post-treatment periods in 32 separate procedures is shown in Fig. 5 . The mean (± SD) salivary amylase activities in the pre-, mid-and posttreatment periods were 25.6 ± 23.0, 37.5 ± 32.6 and 34.2 ± 31.8 kU/l, respectively. The result of a one-sample t-test showed that a significant increase in salivary amylase activity was observed in the mid-treatment period compared with the pre-treatment period (P < 0.05). Following most procedures, salivary amylase activity decreased back to the level of the resting state, although there was no significant difference between the mid-and post-treatment periods.
A structural model of the factors that influence the pain indicator during medical procedures performed in people with SMID is shown in Fig. 6 . ∆AMY pre-mid was defined as the change in AMY mid compared with AMY pre , and ∆HR pre-mid was defined as the change in HR mid compared with HR pre . The pass coefficient for the distress and pain levels (medical procedure), salivary amylase activities (β A1 -A3 ) and heart rates (β HR3 ) exhibited positive values except for HR mid and HR post . ∆AMY pre-mid showed a change in salivary amylase activity in the mid-treatment period compared with the pre-treatment period (β A3 = 0.89). These results corresponded well with the results of the t-test shown in Fig. 5 . The pass coefficient for salivary amylase activity ranged from 0.89 to 1.00, while heart rate exhibited low levels that ranged from -0.12 to 0.16. The coefficient of multiple determination of R 2 of the unobserved variable was 0.45.
Discussion
Salivary amylase activity in healthy people and in those with SMID ranges from 27 to 1140 kU/l. 24 -26 In contrast, the mean values in salivary amylase activity and heart rate of patients C, E, G, I and J who were supported by artificial respiration (because of severe brain damage) were smaller than those of the patients who were not severely brain damaged and who did not need artificial respiration. If the changes in salivary amylase activity had arisen from spinal reflexes stimulated by gastric and bronchial tube exchange, the influence of severe brain damage would be expected to be smaller than that observed. Our findings suggest that there is a correlation between severe brain damage and salivary amylase activity.
FIGURE 6:
A structural model detailing the factors that influence the pain indicator during medical procedures performed in patients with severe motor and intellectual disabilities who were enrolled in a study of biochemical non-verbal communication (n = 10). ∆AMY pre-mid , subtract AMY pre from AMY mid ; ∆HR pre-mid , subtract HR pre from HR mid ; AMY pre , mean amylase activity during the pre-treatment period; HR pre , mean heart rate during the pre-treatment period; AMY mid , maximum amylase activity during the medical procedure; HR mid , maximum heart rate during the medical procedure; AMY post , mean amylase activity during the post-treatment period; HR post , mean heart rate during the post-treatment period 
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We observed a significant increase in salivary amylase activity as a result of medical procedures performed in people with SMID. In addition, the salivary amylase activity tended to decrease after the procedure was complete. Patients A, B, C, E and J have been bedridden for over 20 years, which has caused severe torticollis. Therefore, gastric tube insertion was extremely difficult in these patients. As a result, patients A, B and C often choked and demonstrated facial flushing during the medical procedure, which was assumed to be a cause of the significant changes that were observed in salivary amylase activity and heart rate.
The medical procedures performed in individuals with SMID resulted in a significant mean increase of 70% in salivary amylase activity, but only a 15.1% mean increase in heart rate. In the SEM analysis, as the pass coefficient of HR mid and HR post were negative values, while the pass coefficients for others were positive values, it was considered that the unobserved variable indicated pain. Furthermore, the pass coefficient of salivary amylase exceeded 0.8, which was far better than that of heart rate. Our findings suggest that heart rate would M Yamaguchi, K Takeda, M Onishi et al.
not be a useful index of pain in patients with SMID, but that salivary amylase activity could be a promising biochemical indicator of pain levels.
Laboured breathing could be avoided if the bronchial tube exchange was completed within 15 s. The pain associated with gastric tube exchange seemed to be a little greater than that associated with bronchial tube exchange because the pass coefficient of the pain level showed a small positive value (β M = 0.16).
Although there have been other attempts to find non-verbal methods of measuring the physical and psychological status of healthy people, 14 -16 there have been few investigations of non-verbal communication in people with SMID. Part of the reason for this has been the lack of a non-invasive method that could be used rapidly, easily and without stress to the patient. Our study suggests that the biochemical marker, salivary amylase activity, could be a useful pain indicator for people with SMID. If a non-verbal method of communication could be validated, then the emotions of people with SMID could be objectively assessed. Caregivers would then be able to measure reliably any pain or discomfort associated with medical procedures that they perform in people with SMID, which would allow them to improve their techniques or choose appropriate training methods in order to reduce pain and discomfort. Furthermore, a clearer understanding of when a person with SMID is in pain or discomfort may help to improve their quality of life.
Our results indicated that: (i) There was a correlation between severe brain damage and salivary amylase secretion; (ii) Medical procedures performed in people with SMID resulted in a significant change in salivary amylase activity; (iii) Salivary amylase activity would be a more useful pain indicator than heart rate for people with SMID; and (iv) The pain associated with gastric tube exchange was a little greater than that associated with bronchial tube exchange.
